RE:Treat 1% of 1.6M U.S. Diabetes 1 Patients This info has been published many many moons ago by SVA and brought up in nearly every presentation since. Google Sernova Payor survey if you don't believe me. Nothing in that presentation was new except patient 7 selected and due for implant of larger pouch in mid october. Results not expected till mid next year assuming they actually hit the timelines. THey've been talking about patient 7 for over a year now. Share price is going nowhere but down based on what I heard today. Nothing in the nearterm to lift it that the company is doing or planning other than warrants expiring. Most of those people will likely cash in and sell those as well. You could sit on your shares for a couple years and hope all the experiments go well and all the competitions don't. Unlikely scenario however. The space is heating up and all we have is a piece of plastic. If someone came out with a new device design today, they could be in the clinic testing it before sernova even gets the Evotec cells in humans. I guess that's the speed you run at when you're a micro managing one man show.